F
FDA
Guest
This workshop is intended for interested parties regarding ongoing efforts; parties interested in continued advocacy for alternatives to traditional dose finding for oncologic drugs. The primary audience includes, clinical pharmacologists, pharmacometricians, pharmacologists/toxicologists, clinicians/healthcare providers, statisticians, patients, a
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...